基于专利视角的京津冀医药制造业协同创新评价
|
摘要
京津冀协同发展已上升到国家战略,其产业协同创新情况到底如何,值得深入研究。选取京津冀地区的医药制造业作为研究对象,采用其1995—2015年相关专利数据建立复合系统协同度模型,对区域内部医药制造业各自和整体的协同度进行测算评价。研究结果表明:(1)区域内专利指标的序参量呈现逐年上升的趋势,说明京津冀地区医药制造业专利方面的创新趋于有序;(2)区域内协同创新子系统中专利价值子系统的重要地位逐渐显现;(3)京津冀医药制造业协同创新水平不断提升,但目前整体协同创新程度仍居于中等水平。
The collaborative development of Beijing-Tianjin-Hebei has come to a national strategy, and the process of the collaborative innovation deserve to be studied deeply.This paper selects Beijing, Tianjin and Hebei as the object, describing and analyzing several indicators about pharmaceutical manufacturing of past few years, and then we take data of pharmaceutical manufacturing in Beijing, Tianjin and Hebei range from 1995 to 2015, which related to patent. Based on these data, we set a composite system synergy model to calculate collaborative degree for both the internal pharmaceutical manufacturing respectively and the whole process, which shows that:(1) The trend of order parameter related to patent indicators is increasing, which tells that the creativity in patent is getting better;(2) The importance of patent value subsystem is getting obvious;(3) The collaborative innovation in pharmaceutical manufacturing in Beijing, Tianjin and Hebei is improving quickly, but it still stick on the medium level. So it is still necessary to coordinate the internal subsystem to make sure there will be a high level of collaborative innovation.
The collaborative development of Beijing-Tianjin-Hebei has come to a national strategy, and the process of the collaborative innovation deserve to be studied deeply.This paper selects Beijing, Tianjin and Hebei as the object, describing and analyzing several indicators about pharmaceutical manufacturing of past few years, and then we take data of pharmaceutical manufacturing in Beijing, Tianjin and Hebei range from 1995 to 2015, which related to patent. Based on these data, we set a composite system synergy model to calculate collaborative degree for both the internal pharmaceutical manufacturing respectively and the whole process, which shows that:(1) The trend of order parameter related to patent indicators is increasing, which tells that the creativity in patent is getting better;(2) The importance of patent value subsystem is getting obvious;(3) The collaborative innovation in pharmaceutical manufacturing in Beijing, Tianjin and Hebei is improving quickly, but it still stick on the medium level. So it is still necessary to coordinate the internal subsystem to make sure there will be a high level of collaborative innovation.
引文
[1]天津市人民政府.关于印发京津冀生物医药产业化示范区优惠政策的通知[Z].天津:天津市人民政府,2008-08-13.
[2]金新伟.创新思路京津冀启动医药产业协同发展[N].中国工业报,2015-04-20(B1)
[3]HERMANN HAKEN.Synergetics:an introdution[M].New York:Springer-Verlag,1977:260.
[4]FREEMAN C.Networks of innovators:a synthesis of research issues[J].Research Policy,1991,20(5):499-514.
[5]彭纪生.中国技术协同创新[M].北京:中国经济出版社,2000:85-104.
[6]王志宝,孙铁山,李国平.区域协同创新研究进展与展望[J].软科学,2013,27(1):1-4.
[7]马昱,张永安,高瑀.医药制造业科技投入与技术创新关系研究:基于京津冀医药制造业协同发展战略的思考[J].价格理论与实践,2016(12):147-150.
[8]李晓梅,王伟光,考燕鸣.东北地区医药制造业技术创新能力实证研究[J].中国科技论坛,2009(11):39-42.
[9]顼玉卿,聂雅,索贵彬.基于知识链的制药产业协同创新研究:以我国医药制造业为例[J].科技进步与对策,2015,32(16):57-62.
[10]马澜,朱佩枫.我国医药制造业发展的协同度研究[J].管理现代化,2014(6):22-24.
[11]于延顺,于丽艳,陈伟.协同视角下企业专利管理实证研究:以医药制造业企业为例[J].情报杂志,2011,30(7):85-88.
[12]龚关.基于专利信息的产业技术创新能力评价研究[D].上海:华东师范大学,2012.
[13]焦敬娟,王姣娥,刘志高.东北地区创新资源与产业协同发展研究[J].地理科学,2016,36(9):1338-1348.
[14]王国红,梁晓燕,邢蕊.区域协同创新网络的结构风险研究:以国内外生物医药基地的对比分析为例[J].当代经济管理,2014,36(7):17-22.
[15]ASHISH ARORA,SUMA ATHREYE,HUANG CAN.The paradox of openness revisited:collaborative innovation and patenting[J].UK Innovators,2016(45):1352-1361.
[16]刘志迎,单洁含.技术距离、地理距离与大学-企业协同创新效应:基于联合专利数据的研究[J].科学学研究,2013,31(9):1331-1336.
[17]周青,陈畴镛.专利联盟提升企业自主创新能力的作用方式与政策建议[J].科研管理,2012,33(1):41-46.
[18]党兴华,弓志刚.多维临近性对跨区域技术创新合作的影响:基于中国共同专利数据的实证分析[J].科学学研究,2013,31(10):1590-1599.
[19]洪勇,李英敏.基于专利耦合的企业间技术相似性可视化研究[J].科学学研究,2013,31(7):1013-1020.
[20]王崇锋,徐恒博,张古鹏.城市区域创新能力差异研究:基于专利质量的视角[J].山东大学学报(哲学社会科学版),2014(1):74-80.
[21]石亮,张善杰,陈伟炯.从专利角度看上海高校科技创新能力现状及提升对策[J].研究与发展管理,2014,26(3):115-121.
[22]朱凌,薛萍,徐旋.高校与区域的协同创新:基于我国典型区域10年专利数据的实证分析[J].高等工程教育研究,2014(4):15-21.
[23]谢光亚,李明哲.基于专利信息的中国风电产业技术创新能力评价[J].工业技术经济,2013(8):3-10.
[24]金泳锋.中国高技术产业专利活动实证研究:以卫星产业为例[J].科技管理研究,2015,32(3):70-74.
[2]金新伟.创新思路京津冀启动医药产业协同发展[N].中国工业报,2015-04-20(B1)
[3]HERMANN HAKEN.Synergetics:an introdution[M].New York:Springer-Verlag,1977:260.
[4]FREEMAN C.Networks of innovators:a synthesis of research issues[J].Research Policy,1991,20(5):499-514.
[5]彭纪生.中国技术协同创新[M].北京:中国经济出版社,2000:85-104.
[6]王志宝,孙铁山,李国平.区域协同创新研究进展与展望[J].软科学,2013,27(1):1-4.
[7]马昱,张永安,高瑀.医药制造业科技投入与技术创新关系研究:基于京津冀医药制造业协同发展战略的思考[J].价格理论与实践,2016(12):147-150.
[8]李晓梅,王伟光,考燕鸣.东北地区医药制造业技术创新能力实证研究[J].中国科技论坛,2009(11):39-42.
[9]顼玉卿,聂雅,索贵彬.基于知识链的制药产业协同创新研究:以我国医药制造业为例[J].科技进步与对策,2015,32(16):57-62.
[10]马澜,朱佩枫.我国医药制造业发展的协同度研究[J].管理现代化,2014(6):22-24.
[11]于延顺,于丽艳,陈伟.协同视角下企业专利管理实证研究:以医药制造业企业为例[J].情报杂志,2011,30(7):85-88.
[12]龚关.基于专利信息的产业技术创新能力评价研究[D].上海:华东师范大学,2012.
[13]焦敬娟,王姣娥,刘志高.东北地区创新资源与产业协同发展研究[J].地理科学,2016,36(9):1338-1348.
[14]王国红,梁晓燕,邢蕊.区域协同创新网络的结构风险研究:以国内外生物医药基地的对比分析为例[J].当代经济管理,2014,36(7):17-22.
[15]ASHISH ARORA,SUMA ATHREYE,HUANG CAN.The paradox of openness revisited:collaborative innovation and patenting[J].UK Innovators,2016(45):1352-1361.
[16]刘志迎,单洁含.技术距离、地理距离与大学-企业协同创新效应:基于联合专利数据的研究[J].科学学研究,2013,31(9):1331-1336.
[17]周青,陈畴镛.专利联盟提升企业自主创新能力的作用方式与政策建议[J].科研管理,2012,33(1):41-46.
[18]党兴华,弓志刚.多维临近性对跨区域技术创新合作的影响:基于中国共同专利数据的实证分析[J].科学学研究,2013,31(10):1590-1599.
[19]洪勇,李英敏.基于专利耦合的企业间技术相似性可视化研究[J].科学学研究,2013,31(7):1013-1020.
[20]王崇锋,徐恒博,张古鹏.城市区域创新能力差异研究:基于专利质量的视角[J].山东大学学报(哲学社会科学版),2014(1):74-80.
[21]石亮,张善杰,陈伟炯.从专利角度看上海高校科技创新能力现状及提升对策[J].研究与发展管理,2014,26(3):115-121.
[22]朱凌,薛萍,徐旋.高校与区域的协同创新:基于我国典型区域10年专利数据的实证分析[J].高等工程教育研究,2014(4):15-21.
[23]谢光亚,李明哲.基于专利信息的中国风电产业技术创新能力评价[J].工业技术经济,2013(8):3-10.
[24]金泳锋.中国高技术产业专利活动实证研究:以卫星产业为例[J].科技管理研究,2015,32(3):70-74.